Neurosurgery

Amylyx Pharmaceuticals Announces Publication of Data Showing the Effect of AMX0035 on Plasma Neuroinflammatory Biomarkers in ALS

Retrieved on: 
Monday, December 4, 2023
Health, Genetics, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Amylyx Pharmaceuticals, Barrow Neurological Institute, CRP, Chitinase, ALS, Plasma, Disease, Journal, Week, Psychiatry, Survival, Journal of Neurology, AMX0035, Doctor of Philosophy, Biomarker, C-reactive protein, Cerebrospinal fluid, Medication, Neurosurgery, HIV disease progression rates, ITT, Medical imaging, Neurology, PHOENIX

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the publication of analyses performed on neuroinflammatory biomarkers using plasma samples from participants with amyotrophic lateral sclerosis (ALS) from the Phase 2 CENTAUR trial.

Key Points: 
  • Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the publication of analyses performed on neuroinflammatory biomarkers using plasma samples from participants with amyotrophic lateral sclerosis (ALS) from the Phase 2 CENTAUR trial.
  • During the CENTAUR trial, plasma samples were prospectively collected from trial participants for future biomarker analyses.
  • “Neuroinflammatory biomarkers are important for assessing disease progression and therapeutic response in ALS with chitinases and CRP emerging as potential treatment response biomarkers.
  • Further analyses of neuroinflammatory biomarkers are planned in the ongoing Phase 3 PHOENIX trial to confirm these results.

Global Surgical Kits Strategic Market Report 2023-2030 with Competitive Analysis of 250+ Competitors - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 14, 2023
Surgery, Health, Medical Supplies, Ophthalmology, Compound annual growth rate, Gynaecology, Data, Growth, Neurosurgery, Kits, Reusability, Hospital, General surgery, Medical device, Pet industry

The "Surgical Kits - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Surgical Kits - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
  • Furthermore, it delves into various surgical specialties, including general surgery, cardiac surgery, ophthalmology, orthopedic surgery, neurosurgery, gynecology, and other procedures.
  • The Surgical Kits market in the U.S. is estimated at US$6.6 Billion in the year 2022.
  • The report features analysis of up to 252 competitors, providing you robust comparative data and strategic insights to traverse through your industry voyage confidently.

Robotic Surgery Pioneer Virtuoso Surgical Awarded $1.8 Million in SBIR Funding

Retrieved on: 
Tuesday, November 14, 2023
Technology, Radiology, Health Technology, Oncology, Other Science, Research, Medical Devices, Hospitals, Clinical Trials, Biotechnology, Health, Robotics, Women, Seniors, Managed Care, Men, Nanotechnology, Science, Consumer, Medical Supplies, FDA, Hardware, Surgery, Sale, Otorhinolaryngology, Virtuoso, Cadaver, Gynaecology, Lead (engineering), Entrepreneurship, VISE, Surgeon, Elective surgery, Bladder cancer, SBIR, FACS, ENT, NIH, Neurosurgery, Cancer, BPH, Endoscopy, Small Business Innovation Research, Doctor of Philosophy, Uterine fibroid, Medical device, MD, Engineering

Medical device company Virtuoso Surgical, Inc. has been awarded a $1.8 million Small Business Innovation Research (SBIR) NIH grant to be received over the next two years.

Key Points: 
  • Medical device company Virtuoso Surgical, Inc. has been awarded a $1.8 million Small Business Innovation Research (SBIR) NIH grant to be received over the next two years.
  • Virtuoso’s robotic surgery system enables a new scale of robotic tools and maneuvers in endoscopic surgery that are not possible using today’s instruments.
  • “We are honored to receive this SBIR Phase II grant as we move toward commercialization of our groundbreaking robotic surgical system ,” said S. Duke Herrell, III, MD, FACS , CEO, Co-Founder and Chief Medical Officer of Virtuoso Surgical.
  • They developed the Virtuoso Surgical system with a design team helmed by COO, Co-founder and Lead Engineer Richard Hendrick, PhD.

Now Open, the Verstandig Pavilion at MedStar Georgetown University Hospital, Providing World-Class Care in a World-Class Facility

Retrieved on: 
Wednesday, December 13, 2023
Medicine, Anatomy, Risk, Surgeon, Brain, Patient, Multimedia, Intensive care medicine, MedStar Georgetown University Hospital, MedSTAR, IMRIS, Neurosurgery, Perioperative, MedStar Health, Electrode, Operating, Health, Hospital, Medical imaging, MD, Jesuits

WASHINGTON, Dec. 13, 2023 /PRNewswire/ -- MedStar Georgetown University Hospital and MedStar Health proudly announce the opening of the new Verstandig Pavilion, a transformative project for the region.

Key Points: 
  • WASHINGTON, Dec. 13, 2023 /PRNewswire/ -- MedStar Georgetown University Hospital and MedStar Health proudly announce the opening of the new Verstandig Pavilion, a transformative project for the region.
  • This facility enables MedStar Georgetown to continue providing world-class care now in a world-class facility unlike anywhere else in the metropolitan area.
  • "The Verstandig Pavilion is a transformational facility," said Mike Sachtleben, senior vice president and chief operating officer, Washington Region, MedStar Health and has been involved in the pavilion project from the very beginning.
  • To learn more about what the Verstandig Pavilion provides, please visit https://www.medstarhealth.org/building-medical-excellence
    View original content to download multimedia: https://www.prnewswire.com/news-releases/now-open-the-verstandig-pavilio...

Society of NeuroInterventional Surgery Congratulates President Mahesh Jayaraman, MD, FACR, on Appointment as Chair of Department of Diagnostic Imaging at Brown's Warren Alpert Medical School

Retrieved on: 
Wednesday, December 13, 2023
Health, Neck, Brain, Research, Policy, EMS, Head, Spine, Book, Get Ahead, Neuroradiology, Patient, Medical imaging, Stroke, Rhode Island Hospital, MD, Neurology, Cerebrovascular disease, Society, Neurosurgery, Alpert Medical School, Diagnosis, Education, Medical device

FAIRFAX, Va., Dec. 13, 2023 /PRNewswire/ -- The Society of NeuroInterventional Surgery (SNIS) congratulates SNIS President Mahesh Jayaraman, MD, FACR, on his promotion to Chair of the Department of Diagnostic Imaging at The Warren Alpert Medical School of Brown University and Chief of Diagnostic Imaging at Lifespan, effective January 1, 2024.

Key Points: 
  • FAIRFAX, Va., Dec. 13, 2023 /PRNewswire/ -- The Society of NeuroInterventional Surgery (SNIS) congratulates SNIS President Mahesh Jayaraman, MD, FACR, on his promotion to Chair of the Department of Diagnostic Imaging at The Warren Alpert Medical School of Brown University and Chief of Diagnostic Imaging at Lifespan, effective January 1, 2024.
  • He will also be appointed the Charles and Elfriede Collis-Frances Weeden Gibson Professor of Diagnostic Imaging.
  • "We are very grateful for his hard work, contributions, and commitment to his patients, and wish him success in his new roles."
  • He also serves as a Professor of Diagnostic Imaging, Neurology, and Neurosurgery at The Warren Alpert Medical School and the Director of the Neurovascular Center at Rhode Island Hospital.

Q'Apel Medical Inc. Launches "Hippo" The New Generation Aspiration System for Stroke Thrombectomy

Retrieved on: 
Tuesday, December 12, 2023
DNA, Prisma Health, Patient, Thrombectomy, FDA, Baylor College of Medicine, Neuron, Stroke, Ambient occlusion, Biomedical sciences, MBA, MD, Physician, Professor, Face, Medical device, Cheetah, Walrus, Medicine, Hippopotamus, Radiology, Neurosurgery

FREMONT, Calif., Dec. 12, 2023 /PRNewswire/ -- Q'Apel Medical Inc. launches a new generation aspiration technology - the 072 Hippo Aspiration System, developed for patients suffering from a stroke due to a large vessel occlusion.

Key Points: 
  • FREMONT, Calif., Dec. 12, 2023 /PRNewswire/ -- Q'Apel Medical Inc. launches a new generation aspiration technology - the 072 Hippo Aspiration System, developed for patients suffering from a stroke due to a large vessel occlusion.
  • The recent FDA cleared stroke system, comprised of the 072 Hippo Aspiration Catheter and its Cheetah companion, represents a paradigm shift in emergent neurovascular intervention.
  • "Our initial experience with the Hippo Aspiration System really demonstrated outstanding system performance.
  • The Hippo Aspiration System also grants us the ability to offer physicians a complete stroke procedure.

A.D.A.M. and the Masovian Regional Hospital Launch Facility Construction to Treat the Victims of Russia's War on Ukraine

Retrieved on: 
Monday, December 11, 2023
POC, GMP, Regional hospital, Patient, JANA, Traumatology, Rehabilitation, Neurosurgery, Trauma, Partnership, 3D, Hospital, Medical device, 3D printing

(Masovian Regional Hospital) signed a Cooperation Agreement to establish an A.D.A.M.

Key Points: 
  • (Masovian Regional Hospital) signed a Cooperation Agreement to establish an A.D.A.M.
  • Point-of-Care (POC) facility in Poland and to utilize the Medical Device Production System (MDPS) to treat patients who require bone implants.
  • The signing took place on the premises of the Masovian Regional Hospital in Siedlce, Poland.
  • investor, states: "Poland has also been instrumental in supporting humanitarian efforts stemming from the Russian war on Ukraine.

Providence Medical Technology Announces New Publication Demonstrating High Fusion Rates and Successful Outcomes in Previously Failed Cervical Fusion Patients

Retrieved on: 
Thursday, December 7, 2023
Risk factor, Neck, Research, FFS, Orthopedic surgery, Duke University, Borat Subsequent Moviefilm, FUSE, Surgeon, Immobilization, Patient, Journal, ACDF, PCF, Nonunion, Success, Pain, Bleeding, Risk, Journal of Clinical Neuroscience, Hospital, Diabetes, Motion, Smoking, Birth control, Dentistry, Pharmaceutical industry, C7, C3, Neurosurgery

PLEASANTON, Calif., Dec. 7, 2023 /PRNewswire/ -- Providence Medical Technology, Inc., a medical device innovator focused on improving surgical outcomes for high-risk spine surgery patients, today announced a new publication in the Journal of Clinical Neuroscience. Dr. Michael M. Haglund and colleagues authored the publication on the long-term outcomes of patients undergoing tissue-sparing Posterior Cervical Fusion (PCF) to revise a 1-level pseudarthrosis following a failed Anterior Cervical Discectomy and Fusion (ACDF).

Key Points: 
  • Dr. Michael M. Haglund and colleagues authored the publication on the long-term outcomes of patients undergoing tissue-sparing Posterior Cervical Fusion (PCF) to revise a 1-level pseudarthrosis following a failed Anterior Cervical Discectomy and Fusion (ACDF).
  • There are over 300,000 cervical fusion procedures performed each year, with over 40% involving patients with some form of risk factors for nonunion.
  • Our tissue-sparing posterior fusion technology is a great option to treat these patients, as is well demonstrated in this study.
  • Providence Medical Technology devices have been used to treat over 20,000 patients and are currently available in over 2,500 hospitals in the United States.

New Patents Strengthen NICO's Intellectual Property Portfolio as It Expands Market Applications for Its Technologies

Retrieved on: 
Tuesday, December 5, 2023
ICH, Brain, Collection, GBM, Patient, NICO, Stroke, Glioblastoma, Neurosurgery, ENRICH, Health, Medical imaging

Ten new patents protect NICO's technology innovations that address unmet needs in treating deadly ICH and brain tumors.

Key Points: 
  • Ten new patents protect NICO's technology innovations that address unmet needs in treating deadly ICH and brain tumors.
  • "It's no coincidence that we have just completed the world's first positive trial in ICH using our patented technology.
  • New breakthroughs in patient care are simply an output of our novel innovation and commitment to minimally invasive neurosurgery."
  • The tremendous value we create for neurosurgeons and the field of neurosurgery is why we are so committed to protecting our intellectual property through the patent process."

Newly Unveiled Verstandig Pavilion at MedStar Georgetown University Hospital Promises Continued World-Class Care in a World-Class Facility

Retrieved on: 
Friday, December 1, 2023
Medicine, Foot, Hope, Nursing, Pavilion, Surgeon, Patient, Multimedia, MedStar Georgetown University Hospital, Health, CBS, MedSTAR, IMRIS, Neurosurgery, Perioperative, MedStar Health, Physician, Emergency department, Operating, Hospital, Medical imaging, MD

WASHINGTON, Nov. 30, 2023 /PRNewswire/ -- MedStar Georgetown University Hospital has officially unveiled the brand new Verstandig Pavilion, which is set to open December 10, 2023. A ribbon cutting ceremony featuring MedStar Health senior leaders, Philanthropist Grant Verstandig, community stakeholders, hospital associates, and CBS Evening News Anchor Norah O'Donnell — the event's emcee — celebrated the hospital's new 477-thousand sq. ft. addition which is set to become the D.C. region's most advanced healthcare facility.

Key Points: 
  • The highly anticipated opening will make MedStar Georgetown home to the Washington, D.C., region's most advanced healthcare facility.
  • WASHINGTON, Nov. 30, 2023 /PRNewswire/ -- MedStar Georgetown University Hospital has officially unveiled the brand new Verstandig Pavilion, which is set to open December 10, 2023.
  • "This is truly a transformational project, creating a world-class facility to match the world-class care provided by our physicians, nurses and associates.
  • "The Verstandig Pavilion will help MedStar Georgetown usher in a new era of healthcare in the region as we continue to serve the health care needs for decades to come."